Microba Life Sciences Limited (ASX:MAP)
Australia
· Delayed Price · Currency is AUD 0.1900
+0.0100 (5.56%)
Apr 28, 2025, 3:52 PM AEST
Microba Life Sciences Revenue
Microba Life Sciences had revenue of 8.08M AUD in the half year ending December 31, 2024, with 275.74% growth. This brings the company's revenue in the last twelve months to 16.90M, up 158.37% year-over-year. In the fiscal year ending June 30, 2024, Microba Life Sciences had annual revenue of 12.09M with 123.06% growth.
Revenue (ttm)
16.90M
Revenue Growth
+158.37%
P/S Ratio
5.03
Revenue / Employee
n/a
Employees
n/a
Market Cap
85.09M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CSL Limited | 24.61B |
| Pro Medicus | 184.58M |
| Cochlear | 2.31B |
| Sonic Healthcare | 9.33B |
| Telix Pharmaceuticals | 783.21M |
| Ramsay Health Care | 17.12B |
| Ansell | 3.00B |
| Mesoblast | 9.16M |